Based on this, the purpose of this study was to establish the level of galectin-3 in serum and assess its relationship with procollagens and the severity of the myocardial fibrosis in patients with MS to determine the possible role of these factors in the occurrence of AF. This evidence concerns the gene LGALS3 and myeloid sarcoma.